Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas. [electronic resource]
Producer: 19940314Description: 864-77 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Animals
- Antibodies, Monoclonal -- metabolism
- Antibody Formation
- Antigens, Neoplasm -- immunology
- Biomarkers, Tumor
- Female
- Gastrointestinal Neoplasms -- therapy
- Half-Life
- Humans
- Immunoglobulin Fab Fragments -- immunology
- Immunoglobulin G -- immunology
- Iodine Radioisotopes -- pharmacokinetics
- Male
- Mice -- immunology
- Middle Aged
- Radioimmunotherapy
- Radiotherapy Dosage
- Tissue Distribution
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.